Health Systems and Services, World Health Organization, Geneva, Switzerland.
Lancet. 2010 Jan 30;375(9712):419-26. doi: 10.1016/S0140-6736(09)61833-X.
Concern that underfunded and weak health systems are impeding the achievement of the health Millennium Development Goals in low-income countries led to the creation of a High Level Taskforce on Innovative International Financing for Health Systems in September, 2008. This report summarises the key challenges faced by the Taskforce and its Working Groups. Working Group 1 examined the constraints to scaling up and costs. Challenges included: difficulty in generalisation because of scarce and context-specific health-systems knowledge; no consensus for optimum service-delivery approaches, leading to wide cost differences; no consensus for health benefits; difficulty in quantification of likely efficiency gains; and challenges in quantification of the financing gap owing to uncertainties about financial commitments for health. Working Group 2 reviewed the different innovative mechanisms for raising and channelling funds. Challenges included: variable definitions of innovative finance; small evidence base for many innovative finance mechanisms; insufficient experience in harmonisation of global health initiatives; and inadequate experience in use of international investments to improve maternal, newborn, and child health. The various mechanisms reviewed and finally recommended all had different characteristics, some focusing on specific problems and some on raising resources generally. Contentious issues included the potential role of the private sector, the rights-based approach to health, and the move to results-based aid. The challenges and disagreements that arose during the work of the Taskforce draw attention to the many issues facing decision makers in low-income countries. International donors and recipient governments should work together to improve the evidence base for strengthening health systems, increase long-term commitments, and improve accountability through transparent and inclusive national approaches.
由于担心资金不足和薄弱的卫生系统正在阻碍低收入国家实现卫生千年发展目标,因此 2008 年 9 月成立了一个卫生系统创新国际融资问题高级别工作队。本报告总结了工作队及其工作组面临的主要挑战。工作组 1 研究了扩大规模和成本的限制因素。面临的挑战包括:由于卫生系统知识稀缺且具体,难以推广;对于最佳服务提供方法没有共识,导致成本差异很大;对于健康效益没有共识;难以量化可能的效率提高;由于对卫生保健财政承诺的不确定性,量化融资缺口方面存在挑战。工作组 2 审查了筹集和输送资金的不同创新机制。面临的挑战包括:创新融资的定义各不相同;许多创新融资机制的证据基础薄弱;全球卫生倡议的协调经验不足;利用国际投资改善孕产妇、新生儿和儿童健康的经验不足。所审查的各种机制最终都有不同的特点,有些机制侧重于具体问题,有些则侧重于筹集资源。有争议的问题包括私营部门的潜在作用、基于权利的卫生方法以及向基于成果的援助转变。工作队工作中出现的挑战和分歧引起了人们对低收入国家决策者所面临的许多问题的关注。国际捐助者和受援国政府应共同努力,为加强卫生系统提供更多证据,增加长期承诺,并通过透明和包容的国家办法提高问责制。